Genentech sends “dear doctor” letters

Share this article:
Genentech has sent a “dear doctor” letter to warn about a higher risk for stroke in patients taking 0.5 mg of Lucentis, indicated for treating wet age-related macular degeneration.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.